Topics
- Page Path
-
- HOME
- TOPICS
- Topics
- Editorial
- Modified quick-SOFA score: Can it enhance prognostic assessment for hospitalized patients with chronic liver diseases?: Editorial on “Dynamic analysis of acute deterioration in chronic liver disease patients using modified quick sequential organ failure assessment”
- Simone Incicco, Salvatore Piano
- Clin Mol Hepatol. 2024;30(4):695-697. Published online June 3, 2024
-
View: 1597 Download: 30 Web of Science: 1 Crossref: 1
- Core protein inhibitors: Opportunities and challenges at the forefront of hepatitis B cure: Editorial on “Phase 1 trial of the safety, pharmacokinetics, and antiviral activity of EDP-514 in untreated viremic chronic hepatitis B patients”
- Hae Lim Lee, Jeong Won Jang
- Clin Mol Hepatol. 2024;30(4):692-694. Published online May 14, 2024
-
View: 1426 Download: 53
- Unveiling etiology-specific blood biomarkers in hepatocellular carcinoma: A gateway to personalized medicine: Editorial on “Multiomics profiling of buffy coat and plasma unveils etiology-specific signatures in hepatocellular carcinoma”
- Joseph C. Ahn, Ju Dong Yang
- Clin Mol Hepatol. 2024;30(4):689-691. Published online May 14, 2024
-
View: 1606 Download: 36 Crossref: 1
- Atezolizumab and bevacizumab for hepatocellular carcinoma: How to approach salvage therapy for non-responders?: Editorial on “Sorafenib vs. Lenvatinib in advanced hepatocellular carcinoma after atezolizumab/bevacizumab failure: A real-world study”
- Naoshi Nishida
- Clin Mol Hepatol. 2024;30(4):682-688. Published online May 7, 2024
-
View: 1940 Download: 102 Crossref: 1
- Meeting the challenges of hepatocellular carcinoma post sustained virologic response in the post-direct- acting antiviral era: A path forward: Editorial on “Unmet needs in the post-direct-acting antivirals era: The risk and molecular mechanisms of hepatocellular carcinoma after hepatitis C virus eradication”
- Seren M. Gedallovich, Paul Y. Kwo
- Clin Mol Hepatol. 2024;30(4):677-681. Published online June 11, 2024
-
View: 1485 Download: 34
- Unlocking the role of liver sinusoidal endothelial cells: Key players in liver fibrosis: Editorial on “Liver sinusoidal endothelial cell: An important yet often overlooked player in the liver fibrosis”
- Yasuko Iwakiri
- Clin Mol Hepatol. 2024;30(4):673-676. Published online May 10, 2024
-
View: 1901 Download: 100 Crossref: 2
- Deep learning assisted biomarker development in patients with chronic hepatitis B: Editorial on “Prognostic role of computed tomography analysis using deep learning algorithm in patients with chronic hepatitis B viral infection”
- Yong Eun Chung
- Clin Mol Hepatol. 2024;30(4):669-672. Published online July 23, 2024
-
View: 1323 Download: 45
- Racial and ethnic disparities in metabolic dysfunction-associated steatotic liver disease outcomes: A call for culturally sensitive interventions: Editorial on “Differences in liver and mortality outcomes of non-alcoholic fatty liver disease by race and ethnicity: A longitudinal real-world study”
- Jae Hyun Bae
- Clin Mol Hepatol. 2024;30(4):665-668. Published online July 29, 2024
-
View: 1569 Download: 88 Web of Science: 3 Crossref: 2
- Elimination of viral hepatitis: How far are we?: Editorial on “Core indicators related to the elimination of hepatitis B and C virus infection in South Korea: A nationwide study”
- Eun Ju Cho
- Clin Mol Hepatol. 2024;30(4):663-664. Published online July 22, 2024
-
View: 1162 Download: 43 Web of Science: 1 Crossref: 1
- Reappraisal of transarterial radioembolization for liver-confined hepatocellular carcinoma with portal vein tumor thrombosis: Editorial on “Transarterial radioembolization versus tyrosine kinase inhibitor in hepatocellular carcinoma with portal vein thrombosis”
- Jin Hyoung Kim, Gun Ha Kim, Dong Il Gwon
- Clin Mol Hepatol. 2024;30(4):659-662. Published online July 17, 2024
-
View: 1414 Download: 83
- Decreasing performance of HCC prediction models during antiviral therapy for hepatitis B: what else to keep in mind: Editorial on “Hepatocellular carcinoma prediction model performance decreases with long-term antiviral therapy in chronic hepatitis B patients”
- Beom Kyung Kim
- Clin Mol Hepatol. 2024;30(4):656-658. Published online July 8, 2024
-
View: 1283 Download: 36 Crossref: 2
- Severity of microvascular invasion does matter in hepatocellular carcinoma prognosis: Editorial on “Classification of microvascular invasion of hepatocellular carcinoma: correlation with prognosis and magnetic resonance imaging”
- Abdelrahman M Attia, Hasmik Adetyan, Ju Dong Yang
- Clin Mol Hepatol. 2024;30(4):653-655. Published online July 1, 2024
-
View: 1611 Download: 64 Web of Science: 1
- Incretin-based therapy in the management of metabolic dysfunction-associated steatotic liver disease (MASLD): one piece of the puzzle: Editorial on “Comparison of glucagon-like peptide-1 receptor agonists and thiazolidinediones on treating nonalcoholic fatty liver disease: A network meta-analysis”
- Tian-Yi Ren, Mohammed Eslam, Jian-Gao Fan
- Clin Mol Hepatol. 2024;30(4):649-652. Published online July 23, 2024
-
View: 2031 Download: 93 Web of Science: 3 Crossref: 2
- Review
- Immunological mechanisms in steatotic liver diseases: An overview and clinical perspectives
- Mengyao Yan, Shuli Man, Long Ma, Lanping Guo, Luqi Huang, Wenyuan Gao
- Clin Mol Hepatol. 2024;30(4):620-648. Published online July 11, 2024
-
View: 3735 Download: 265 Web of Science: 5 Crossref: 6
- Current status and perspective on molecular targets and therapeutic intervention strategy in hepatic ischemia-reperfusion injury
- Jia Liu, Ranyi Luo, Yinhao Zhang, Xiaojiaoyang Li
- Clin Mol Hepatol. 2024;30(4):585-619. Published online July 1, 2024
-
View: 3442 Download: 314 Web of Science: 4 Crossref: 4
- Special Topic
- A new Korean nomenclature for steatotic liver disease
- Nonalcoholic Fatty Liver Disease (NAFLD) Nomenclature Revision Consensus Task Force on behalf of the Korean Association for the Study of the Liver (KASL)
- Clin Mol Hepatol. 2024;30(Suppl):S214-S216. Published online July 1, 2024
-
View: 1706 Download: 91
- Original Article
- Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using vibration-controlled transient elastography: Systematic review and meta-analysis
- Young-Joo Jin, Hee Yeon Kim, Young Ju Suh, Chae Hyeon Lee, Jung Hwan Yu, Mi Na Kim, Ji Won Han, Han Ah Lee, Jihyun An, Young Eun Chon, Dae Won Jun, Miyoung Choi, Seung Up Kim
- Clin Mol Hepatol. 2024;30(Suppl):S159-S171. Published online July 23, 2024
-
View: 1977 Download: 118 Web of Science: 2 Crossref: 1
- Vibration-controlled transient elastography for significant fibrosis in treatment-naïve chronic hepatitis B patients: A systematic review and meta-analysis
- Mi Na Kim, Jihyun An, Eun Hwa Kim, Hee Yeon Kim, Han Ah Lee, Jung Hwan Yu, Young-Joo Jin, Young Eun Chon, Seung Up Kim, Dae Won Jun, Ji Won Han, Miyoung Choi
- Clin Mol Hepatol. 2024;30(Suppl):S106-S116. Published online July 23, 2024
-
View: 1957 Download: 103 Web of Science: 1 Crossref: 3
- Diagnostic accuracy of the Fibrosis-4 index for advanced liver fibrosis in nonalcoholic fatty liver disease with type 2 diabetes: A systematic review and meta-analysis
- Ji Won Han, Hee Yeon Kim, Jung Hwan Yu, Mi Na Kim, Young Eun Chon, Ji Hyun An, Young-Joo Jin, Miyoung Choi, Seung Up Kim, Han Ah Lee, Dae Won Jun
- Clin Mol Hepatol. 2024;30(Suppl):S147-S158. Published online July 25, 2024
-
View: 2141 Download: 130 Web of Science: 4 Crossref: 4
- Prevalence of clinically significant liver fibrosis in the general population: A systematic review and meta-analysis
- Hee Yeon Kim, Jung Hwan Yu, Young Eun Chon, Seung Up Kim, Mi Na Kim, Ji Won Han, Han Ah Lee, Young-Joo Jin, Jihyun An, Miyoung Choi, Dae Won Jun
- Clin Mol Hepatol. 2024;30(Suppl):S199-S213. Published online July 30, 2024
-
View: 2872 Download: 146 Web of Science: 5 Crossref: 6
- Editorial
- Congratulatory remarks
- Yoon Jun Kim
- Clin Mol Hepatol. 2024;30(Suppl):S1-S1. Published online August 8, 2024
-
View: 1274 Download: 23
- Congratulatory remarks
- Won Kim
- Clin Mol Hepatol. 2024;30(Suppl):S2-S2. Published online August 8, 2024
-
View: 1101 Download: 23
- Original Article
- Non-invasive prediction of post-sustained virological response hepatocellular carcinoma in hepatitis C virus: A systematic review and meta-analysis
- Han Ah Lee, Mi Na Kim, Hye Ah Lee, Miyoung Choi, Jung Hwan Yu, Young-Joo Jin, Hee Yeon Kim, Ji Won Han, Seung Up Kim, Jihyun An, Young Eun Chon
- Clin Mol Hepatol. 2024;30(Suppl):S172-S185. Published online August 12, 2024
-
View: 2144 Download: 135 Web of Science: 1 Crossref: 3
- Special Issue
- KASL clinical practice guidelines for noninvasive tests to assess liver fibrosis in chronic liver disease
- Mi Na Kim, Ji Won Han, Jihyun An, Beom Kyung Kim, Young-Joo Jin, Seung-seob Kim, Minjong Lee, Han Ah Lee, Yuri Cho, Hee Yeon Kim, Yu Rim Shin, Jung Hwan Yu, Moon Young Kim, YoungRok Choi, Young Eun Chon, Eun Ju Cho, Eun Joo Lee, Sang Gyune Kim, Won Kim, Dae Won Jun, Seung Up Kim, on behalf of The Korean Association for the Study of the Liver (KASL)
- Clin Mol Hepatol. 2024;30(Suppl):S5-S105. Published online August 19, 2024
-
View: 2933 Download: 221 Web of Science: 6 Crossref: 10
- Original Article
- Assessment of the postoperative prognosis in patients with hepatocellular carcinoma using vibration-controlled transient elastography: A systemic review and meta-analysis
- Jung Hwan Yu, Ji Won Han, Young Ju Suh, Young Eun Chon, Hee Yeon Kim, Ji Hyun An, Young-Joo Jin, Miyoung Choi, Seung Up Kim, Dae Won Jun, Han Ah Lee, Mi Na Kim
- Clin Mol Hepatol. 2024;30(Suppl):S186-S198. Published online August 21, 2024
-
View: 1650 Download: 85 Crossref: 1
- Optimal cut-offs of vibration-controlled transient elastography and magnetic resonance elastography in diagnosing advanced liver fibrosis in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis
- Young Eun Chon, Young-Joo Jin, Jihyun An, Hee Yeon Kim, Miyoung Choi, Dae Won Jun, Mi Na Kim, Ji Won Han, Han Ah Lee, Jung Hwan Yu, Seung Up Kim
- Clin Mol Hepatol. 2024;30(Suppl):S117-S133. Published online August 21, 2024
-
View: 2527 Download: 145 Web of Science: 2 Crossref: 4
- Diagnostic accuracy of vibration-controlled transient elastography for staging liver fibrosis in autoimmune liver diseases: A systematic review and meta-analysis
- Jihyun An, Young Eun Chon, Gunho Kim, Mi Na Kim, Hee Yeon Kim, Han Ah Lee, Jung Hwan Yu, Miyoung Choi, Dae Won Jun, Seung Up Kim, Ji Won Han, Young-Joo Jin
- Clin Mol Hepatol. 2024;30(Suppl):S134-S146. Published online August 21, 2024
-
View: 2261 Download: 127 Web of Science: 1 Crossref: 1
- Snapshot
- Evaluating the therapeutic efficacy of NAD supplementation in management of metabolic dysfunction-associated steatotic liver disease: Key considerations
- Xinyi Lu, Rui Yang, Yu Chen, Daozhen Chen
- Clin Mol Hepatol. 2024;30(3):582-584. Published online December 29, 2023
-
View: 9386 Download: 102
-
Clinical and
Molecular
HepatologyPrint ISSN: 2287-2728
Online ISSN: 2287-285X
-
-
Video abstract
-
- Metabolic dysfunction-associated steatotic liver disease across women’s reproductive lifespan and issues
- Examining the therapeutic landscape of beta-blockers in portal hypertension
- Immunopathogenesis of liver fibrosis in steatotic liver disease
- Evaluating the therapeutic efficacy of NAD supplementation in management of metabolic dysfunction-associated steatotic liver disease: Key considerations
- Recent updates on pharmacologic therapy in non-alcoholic fatty liver disease
- The role of the hepatic autonomic nervous system
- HBeAg-positive grey-zone patients: Treatment beyond guideline recommendations?
- Systemic therapy in advanced hepatocellular carcinoma
- Epidemiology and updated management for autoimmune liver disease
- Microbiome and metabolomics in alcoholic liver disease
- Personalized medicine in nonalcoholic fatty liver disease
- Acute on chronic liver failure in cirrhosis
- Current status and outcome of liver transplantation in South Korea
- History and future of hepatitis B virus control in South Korea
- Hepatocellular carcinoma statistics in South Korea
Impact Factor14.0First decision
07 Days
Publication after acceptance
04 Days
*Last 12 months
- MOST VIEWED (Last 6 months)
- MOST CITED (2023-2025)
|
|||||||
